AAV Anti-Influenza Antibody Patent EP3307310A2
Summary
The European Patent Office published patent application EP3307310A2 for AAV-mediated expression of anti-influenza antibodies, filed by The Trustees of The University of Pennsylvania. The application names Maria P. Limberis, Anna P. Tretiakova, and James M. Wilson as inventors and classifies under IPC A61K 39/12. The patent designates all 35 EU member states plus Albania, Switzerland, the United Kingdom, Turkey, and other European countries.
About this source
GovPing monitors EPO Patent Bulletin - Pharma (A61K) for new healthcare & life sciences regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 72 changes logged to date.
What changed
The European Patent Office published application EP3307310A2 covering AAV vectors engineered to express anti-influenza antibodies and methods of use. The application names The Trustees of The University of Pennsylvania as applicants, with LIMBERIS, TRETIAKOVA, and WILSON as named inventors.
Pharmaceutical and biotechnology companies developing influenza therapeutics or AAV-based antibody delivery platforms should review the patent's claims for potential licensing needs or freedom-to-operate considerations. The designation of all EU states plus multiple European countries means the IP position could affect market entry strategies across Europe.
Archived snapshot
Apr 25, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
AAV-MEDIATED EXPRESSION OF ANTI-INFLUENZA ANTIBODIES AND METHODS OF USE THEREOF
Publication EP3307310A2 Kind: A2 Apr 15, 2026
Applicants
The Trustees of The University of Pennsylvania
Inventors
LIMBERIS, Maria, P., TRETIAKOVA, Anna, P., WILSON, James, M.
IPC Classifications
A61K 39/12 20060101AFI20171205BHEP
Designated States
AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
Related changes
Get daily alerts for EPO Patent Bulletin - Pharma (A61K)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from EPO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when EPO Patent Bulletin - Pharma (A61K) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.